{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:28:20Z","timestamp":1759483700698},"reference-count":125,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.semnephrol.2012.12.012","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T15:39:13Z","timestamp":1362584353000},"page":"106-117","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of Mineral Metabolites as Risk Factors for Adverse Clinical Outcomes in CKD"],"prefix":"10.1016","volume":"33","author":[{"given":"Tamara","family":"Isakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2012.12.012_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib2","series-title":"USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States","year":"2010"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib4","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorders (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(81)90791-1","article-title":"The horse-racing effect","volume":"2","author":"Peto","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.11721111","article-title":"Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol","volume":"7","author":"Isakova","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib8","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2215\/CJN.04290511","article-title":"Fibroblast growth factor 23 in patients undergoing peritoneal dialysis","volume":"6","author":"Isakova","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib9","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib11","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of phosphorus and calcium-phosphorus product with mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5414\/CNP73268","article-title":"Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease","volume":"73","author":"Kovesdy","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib15","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1681\/ASN.2005101101","article-title":"Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease","volume":"17","author":"Norris","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2215\/CJN.07810910","article-title":"Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction","volume":"6","author":"Bellasi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.ajkd.2010.07.016","article-title":"Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study","volume":"56","author":"Landray","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition","volume":"22","author":"Zoccali","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib22","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1681\/ASN.2011080833","article-title":"Phosphate REINs in the renoprotective benefit of ACE inhibition","volume":"22","author":"Block","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib23","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","article-title":"Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease","volume":"26","author":"O'Seaghdha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib25","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjmed.2008.09.039","article-title":"Serum phosphorus and cardiovascular mortality in type 2 diabetes","volume":"122","author":"Chonchol","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib27","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1681\/ASN.2008101106","article-title":"Dietary phosphorus acutely impairs endothelial function","volume":"20","author":"Shuto","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1081\/JDI-100001291","article-title":"Parathormone, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients","volume":"23","author":"Strozecki","year":"2001","journal-title":"Ren Fail"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000046970","article-title":"Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis","volume":"19","author":"Galetta","year":"2001","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000203348","article-title":"Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study","volume":"32","author":"Foley","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000323551","article-title":"Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease","volume":"33","author":"Thadhani","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/heartjnl-2011-300570","article-title":"Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study","volume":"98","author":"Chue","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2012.303","article-title":"Dietary phosphorus is associated with greater left ventricular mass","author":"Yamamoto","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib35","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2005040392","article-title":"Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study","volume":"16","author":"Ayus","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib36","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1681\/ASN.2006080923","article-title":"Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?","volume":"17","author":"Achinger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib38","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib39","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib42","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2215\/CJN.00810110","article-title":"Serum phosphate and mortality in patients with chronic kidney disease","volume":"5","author":"Eddington","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib43","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.ajkd.2010.06.011","article-title":"Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD","volume":"56","author":"Kovesdy","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib45","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1681\/ASN.2005050496","article-title":"Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure","volume":"16","author":"Markowitz","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib46","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ki.1985.79","article-title":"Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil","volume":"27","author":"Goligorsky","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0272-6386(12)80968-1","article-title":"Increased nephron oxygen consumption: potential role in progression of chronic renal disease","volume":"23","author":"Schrier","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib48","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib49","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000123691.46138.E2","article-title":"Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies","volume":"15","author":"Weiner","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib50","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib51","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib52","doi-asserted-by":"crossref","first-page":"c54","DOI":"10.1159\/000228076","article-title":"Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients","volume":"113","author":"Schumock","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00223-009-9283-1","article-title":"Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy","volume":"85","author":"Fisher","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000239757","article-title":"Parathyroid hormone as a mortality predictor in frail aged inpatients","volume":"55","author":"Bjorkman","year":"2009","journal-title":"Gerontology"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib55","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.02640311","article-title":"Serum 25hydroxyvitamin D and change in estimated glomerular filtration rate","volume":"6","author":"de Boer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib56","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib57","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","article-title":"Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP)","volume":"53","author":"Bhuriya","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib58","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.111.179135","article-title":"Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study","volume":"58","author":"Deo","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2011.05.005","article-title":"Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?","volume":"162","author":"Anderson","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib60","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurjhf\/hfq134","article-title":"Plasma parathyroid hormone and risk of congestive heart failure in the community","volume":"12","author":"Hagstrom","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib61","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"Saleh","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib62","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community","volume":"119","author":"Hagstrom","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib63","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib64","first-page":"1","article-title":"PTH\u2013a particularly tricky hormone: why measure it at all in kidney patients?","volume":"7","author":"Garrett","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib65","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib66","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI110137","article-title":"Effect of parathyroid hormone on rat heart cells","volume":"67","author":"Bogin","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib67","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0272-6386(97)90484-4","article-title":"Effects of excess PTH on nonclassical target organs","volume":"30","author":"Bro","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib68","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib69","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib70","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib72","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2009030283","article-title":"25hydroxyvitamin D levels, race, and the progression of kidney disease","volume":"20","author":"Melamed","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib74","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.jrn.2010.07.002","article-title":"Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions","volume":"21","author":"Isakova","year":"2011","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib75","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib76","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1532-5415.2009.02359.x","article-title":"Prospective study of serum 25hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults","volume":"57","author":"Ginde","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib77","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","article-title":"Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population","volume":"106","author":"Anderson","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib78","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","article-title":"25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study","volume":"168","author":"Giovannucci","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib80","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/eurheartj\/ehq246","article-title":"Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients","volume":"31","author":"Drechsler","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2011.10.023","article-title":"Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients","volume":"220","author":"Chitalia","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ajh.2011.12","article-title":"Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults","volume":"24","author":"Harris","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib83","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0b013e3182211b3b","article-title":"Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events","author":"Lishmanov","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib84","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.06510909","article-title":"Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters","volume":"5","author":"Matias","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib85","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ki.2009.288","article-title":"Chronic kidney disease, hypovitaminosis D, and mortality in the United States","volume":"76","author":"Mehrotra","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib86","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.ajkd.2011.04.028","article-title":"Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD","volume":"58","author":"Navaneethan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib87","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3945\/ajcn.111.014779","article-title":"Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies","volume":"95","author":"Zittermann","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib89","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib90","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib91","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib92","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/aje\/kwr258","article-title":"Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study","volume":"174","author":"Shoben","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib93","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinternmed.2008.604","article-title":"Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004","volume":"169","author":"Ginde","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib94","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1373\/clinchem.2011.180562","article-title":"25-hydroxyvitamin D: a difficult analyte","volume":"58","author":"Carter","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib95","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/jbmr.387","article-title":"Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship","volume":"26","author":"Powe","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ki.2012.19","article-title":"Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients","volume":"82","author":"Bhan","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib97","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib98","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat","volume":"286","author":"Kuhlmann","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib99","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib100","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib101","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/07853890.2010.543923","article-title":"Extra-skeletal effects of vitamin D deficiency in chronic kidney disease","volume":"43","author":"Chonchol","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib102","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib103","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF23 as a predictor of renal outcome in diabetic nephropathy","volume":"6","author":"Titan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2215\/CJN.08070811","article-title":"Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women","volume":"7","author":"Semba","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib105","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib106","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib107","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","article-title":"Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease","volume":"161","author":"Taylor","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib108","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","article-title":"The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation","volume":"32","author":"Seiler","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib109","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfr316","article-title":"FGF23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4","volume":"27","author":"Ford","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1542-4758.2011.00630.x","article-title":"FGF23 is associated with cardiac troponin T and mortality in hemodialysis patients","volume":"16","author":"Holden","year":"2012","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib111","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib112","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000321368","article-title":"Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy","volume":"31","author":"Canziani","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib114","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gfq539","article-title":"Serum fibroblast growth factor-23 (FGF23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients","volume":"26","author":"Kirkpantur","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib115","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib116","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2215\/CJN.08680811","article-title":"Combined use of vitamin D status and FGF23 for risk stratification of renal outcome","volume":"7","author":"Nakano","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib117","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/ndt\/gfr596","article-title":"Residual renal function is an independent determinant of serum FGF23 levels in dialysis patients","volume":"27","author":"Viaene","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib118","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2008-0326","article-title":"Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis","volume":"94","author":"Wesseling-Perry","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib119","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib120","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib121","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and inflammation in chronic kidney disease","volume":"7","author":"Munoz Mendoza","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib122","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","article-title":"Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease","volume":"21","author":"Manghat","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib123","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc11-2235","article-title":"Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease","volume":"35","author":"Wahl","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib124","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.012_bib125","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929512002744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929512002744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:06:59Z","timestamp":1715036819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929512002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0270929512002744"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2012.12.012","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}